Literature DB >> 18585434

Twenty-five years of research on bovine lactoferrin applications.

Mamoru Tomita1, Hiroyuki Wakabayashi, Kouichirou Shin, Koji Yamauchi, Tomoko Yaeshima, Keiji Iwatsuki.   

Abstract

Lactoferrin (LF) was identified as a milk protein in 1960. Large-scale manufacturing of bovine LF (bLF) was established more than 20 years ago. Using this commercially available material, research for bLF applications has advanced from basic studies to clinical studies, and bLF has been applied to commercial food products for the last 25 years. During this period, it was found that LF is digested by gastric pepsin to generate a multi-potent peptide, lactoferricin. It was also demonstrated that oral administration of bLF augments host protection against infections via antimicrobial action and immunomodulation of the host. In addition, researchers have demonstrated that oral administration of bLF prevents cancer development. In this review, we look back on 25 years of bLF research and development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585434     DOI: 10.1016/j.biochi.2008.05.021

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  38 in total

1.  Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB.

Authors:  Yu-Hsuan Ho; Tzu-Cheng Sung; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2011-12-02       Impact factor: 5.911

2.  Effect of glucose on the lactoferrin's conformation and its effect on MC 3T3-E1 cell proliferation.

Authors:  Pengcheng Wen; Huiyuan Guo; Hao Zhang; Bozhong Gan; Qingbo Ding; Fazheng Ren
Journal:  Protein J       Date:  2012-04       Impact factor: 2.371

Review 3.  Effects of dairy intake on hyperuricemia and gout.

Authors:  Nicola Dalbeth; Kate Palmano
Journal:  Curr Rheumatol Rep       Date:  2011-04       Impact factor: 4.592

4.  Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.

Authors:  J L Hayworth; K J Kasper; M Leon-Ponte; C A Herfst; D Yue; W C Brintnell; D M Mazzuca; D E Heinrichs; E Cairns; J Madrenas; D W Hoskin; J K McCormick; S M M Haeryfar
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

Review 5.  Immunomodulatory effects of lactoferrin.

Authors:  Tania Siqueiros-Cendón; Sigifredo Arévalo-Gallegos; Blanca Flor Iglesias-Figueroa; Isui Abril García-Montoya; José Salazar-Martínez; Quintín Rascón-Cruz
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

6.  Development of dairy herd of transgenic goats as biofactory for large-scale production of biologically active recombinant human lactoferrin.

Authors:  I Semak; A Budzevich; E Maliushkova; V Kuzniatsova; N Popkov; I Zalutsky; O Ivashkevich
Journal:  Transgenic Res       Date:  2019-08-08       Impact factor: 2.788

Review 7.  Clinical applications of bioactive milk components.

Authors:  David R Hill; David S Newburg
Journal:  Nutr Rev       Date:  2015-07       Impact factor: 7.110

8.  Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.

Authors:  Jian-Ming Hou; Ying Xue; Qing-Ming Lin
Journal:  Acta Pharmacol Sin       Date:  2012-08-20       Impact factor: 6.150

9.  Characterization of goat milk lactoferrin N-glycans and comparison with the N-glycomes of human and bovine milk.

Authors:  Annabelle Le Parc; David C Dallas; Solene Duaut; Joelle Leonil; Patrice Martin; Daniela Barile
Journal:  Electrophoresis       Date:  2014-03-19       Impact factor: 3.535

10.  Expression and Purification of the Main Component Contained in Camel Milk and Its Antimicrobial Activities Against Bacterial Plant Pathogens.

Authors:  Abbas Tanhaeian; Farajollah Shahriari Ahmadi; Mohammad Hadi Sekhavati; Mojtaba Mamarabadi
Journal:  Probiotics Antimicrob Proteins       Date:  2018-12       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.